How we treat mature B-cell neoplasms (indolent B-cell lymphomas)

How we treat mature B-cell neoplasms (indolent B-cell lymphomas)

Abstract Mature B cell neoplasms, previously indolent non-Hodgkin lymphomas (iNHLs), are a heterogeneous group of malignancies sharing similar disease courses and treatment paradigms. Most patients with iNHL have an excellent prognosis, and in many, treatment can be deferred for years. However, some...

Full description

Bibliographic Details
Main Authors: Melissa Lumish, Lorenzo Falchi, Brandon S. Imber, Michael Scordo, Gottfried von Keudell, Erel Joffe
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Journal of Hematology & Oncology
Subjects:
Indolent lymphoma
Mature B cell neoplasm
Follicular lymphoma
Marginal zone lymphoma
Active surveillance
Online Access:https://doi.org/10.1186/s13045-020-01018-6

Internet

https://doi.org/10.1186/s13045-020-01018-6

Similar Items